Cargando…

Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension

Detalles Bibliográficos
Autores principales:	Lin, Wenchao, Tang, Yiyang, Zhang, Mengqiu, Liang, Benhui, Wang, Meijuan, Zha, Lihuang, Yu, Zaixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800058/ https://www.ncbi.nlm.nih.gov/pubmed/36590941 http://dx.doi.org/10.3389/fmed.2022.1116599

Ejemplares similares

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Zhang, Wen, et al.
Publicado: (2023)

Corrigendum: A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure
por: Tang, Yiyang, et al.
Publicado: (2022)

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China
por: Zeng, Xiaofang, et al.
Publicado: (2021)

Association between prothrombin time-international normalized ratio and prognosis of post-cardiac arrest patients: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2023)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling
por: Li, Tangzhiming, et al.
Publicado: (2020)

Corrigendum: Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2022)

Serum Anion Gap Is Associated with All-Cause Mortality among Critically Ill Patients with Congestive Heart Failure
por: Tang, Yiyang, et al.
Publicado: (2020)

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2023)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
por: Zeng, Haowei, et al.
Publicado: (2021)

Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning
por: Lu, Wenzhang, et al.
Publicado: (2023)

Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis
por: Zou, Hua-Xi, et al.
Publicado: (2021)

Development and Validation of Nomogram to Predict Long-Term Prognosis of Critically Ill Patients with Acute Myocardial Infarction
por: Tang, Yiyang, et al.
Publicado: (2021)

Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study
por: Tang, Yiyang, et al.
Publicado: (2021)

Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses
por: Qiu, Xue, et al.
Publicado: (2021)

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
por: Fu, Binsheng, et al.
Publicado: (2017)

Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis
por: Yang, Zhisong, et al.
Publicado: (2022)

Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
por: Li, Qian, et al.
Publicado: (2023)

Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension
por: Wang, Kuo-Yang, et al.
Publicado: (2015)

Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
por: Foris, Vasile, et al.
Publicado: (2023)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry
por: Minhas, J., et al.
Publicado: (2022)

Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies
por: Yang, Xiaomei, et al.
Publicado: (2022)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification
por: Fu, Bowen, et al.
Publicado: (2022)

Epistatic interactions in idiopathic pulmonary arterial hypertension
por: Vadapalli, Shivani, et al.
Publicado: (2012)

Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis
por: Zeng, Yu, et al.
Publicado: (2021)

Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation
por: Zha, Lihuang, et al.
Publicado: (2020)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
por: Suvorova, Elena S., et al.
Publicado: (2009)

Genetic Variations in TXNRD1 as Potential Predictors of Drug-Induced Liver Injury
por: Kwon, Jae-Woo, et al.
Publicado: (2012)

Selenoprotein TXNRD3 supports male fertility via the redox regulation of spermatogenesis
por: Dou, Qianhui, et al.
Publicado: (2022)

Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy
por: Malekmohammad, Majid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9u2686lv4p44mqur8ur7diussr